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Nitric Oxide Targets Oligodendrocytes and
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Giti Garthwaite, Kathryn Hampden-Smith, Gary W. Wilson, David A. Goodwin,
and John Garthwaite
In the central nervous system, nitric oxide (NO) transmits signals from one neurone to another, or from neurones to astrocytes
or blood vessels, but the possibility of oligodendrocytes being physiological NO targets has been largely ignored. By exploit-
ing immunocytochemistry for cGMP, the second messenger generated on activation of NO receptors, oligodendrocytes were
found to respond to both exogenous and endogenous NO in cerebellar slices from rats aged 8 days to adulthood. Atrial
natriuretic peptide, which acts on membrane-associated guanylyl cyclase-coupled receptors, also raised oligodendrocyte
cGMP in cerebellar slices. The main endogenous source of NO accessing oligodendrocytes appeared to be the neuronal NO
synthase isoform, which was active even under basal conditions and in a manner that was independent of glutamate recep-
tors. Oligodendrocytes in brainstem slices were also shown to be potential NO targets. In contrast, in the optic nerve, oligo-
dendrocyte cGMP was raised by natriuretic peptides but not NO. When cultures of cerebral cortex were continuously
exposed to low NO concentrations (estimated as 40–90 pM), oligodendrocytes responded with a striking increase in arboriza-
tion. This stimulation of oligodendrocyte growth could be replicated by low concentrations of 8-bromo-cGMP (maximum
effect at 1 mM). It is concluded that oligodendrocytes are probably widespread targets for physiological NO (or natriuretic
peptide) signals, with the resulting rise in cGMP serving to enhance their growth and maturation. NO might help coordinate
the myelination of axons to the ongoing level of neuronal activity during development and could potentially contribute to
adaptive changes in myelination in the adult.
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Introduction
Nitric oxide (NO) is a unique, membrane-permeating typeof transmitter that operates throughout the central nerv-
ous system. At this location, NO is generated largely by the
neuronal subtype of NO synthase (nNOS) in response to a
rise in intracellular Ca21, typically brought about through
NMDA receptor channels, and acts in target cells by stimulat-
ing specialized guanylyl cyclase-coupled receptors to generate
cGMP (Garthwaite, 2008; Hardingham et al., 2013; Steinert
et al., 2010). NO from endothelial NO synthase (eNOS)
may also be important for brain function independently of its
role in the control of blood flow in that it has been shown to
regulate the membrane potential of axons in the optic nerve
(Garthwaite et al., 2006) and to participate in synaptic plas-
ticity in the hippocampus (Hopper and Garthwaite, 2006;
Son et al., 1996; Wilson et al., 1999) as well as in various
behaviors (Demas et al., 1999). The main established targets
of endogenously-produced NO in the central nervous system
are neurones and astrocytes and most of the relevant literature
to date has dwelt on these cell types, although neuronally-
derived NO may also act on the microvasculature to regulate
blood flow (Yang et al., 2003).
The possible action of NO on oligodendrocytes has so
far been almost entirely confined to its putative pathological
role in the context of multiple sclerosis (Lassmann, 2011;
Smith and Lassmann, 2002). Such deleterious effects are
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likely to involve NO in high concentrations inhibiting mito-
chondrial respiration and contributing to oxidative/nitrosative
stress through peroxynitrite formation. Nonetheless, there is
evidence that NO contributes to the increased phosphoryla-
tion of myelin basic protein in oligodendrocytes taking place
after high-frequency stimulation of hippocampal axons
(Atkins and Sweatt, 1999). There is also one report that,
based on cGMP immunohistochemistry, NO induces cGMP
accumulation in oligodendrocytes in the corpus callosum in
incubated brain slices from the 2-week-old rat and that this
response diminishes progressively with age thereafter (Tanaka
et al., 1997). This finding points to a potential influence of
NO on oligodendrocyte development. In contrast, no cGMP
accumulation in oligodendrocytes in slices of the developing
(8-day-old) rat hippocampus following NO administration
was found (Bartus et al., 2013). Similarly, in the optic nerve
of 10-day-old (Garthwaite et al., 2006) or adult (Garthwaite
et al., 1999) rats, NO-evoked cGMP accumulation was
prominent in axons but was not detected in oligodendrocytes.
One of the best-studied brain areas with respect to NO-
cGMP signaling is the cerebellum, an area important for
motor control and one in which this pathway contributes to
synaptic plasticity and other phenomena (Contestabile, 2012;
Garthwaite, 2008). cGMP immunohistochemistry and
attempts to locate NO-activated guanylyl cyclase subunits by
in situ hybridization or immunochemistry in the rodent cere-
bellum identify neurones and astrocytes as the main NO tar-
gets (de Vente et al., 1990; Ding et al., 2004; Furuyama
et al., 1993; Gibb and Garthwaite, 2001; Southam et al.,
1992) but no attempt appears to have been made to investi-
gate oligodendrocytes, either during development or in adult-
hood. Following exposure of slices of the developing
cerebellum to exogenous NO, abundant cells in the white
matter were shown to accumulate cGMP but these cells were
considered to be astrocytes (de Vente et al., 1990).
In view of the questionable status of oligodendrocytes as
physiological targets for NO, we have examined the ability of
this cell type to accumulate cGMP in response to exogenous
and endogenous NO, using cGMP immunohistochemistry
and slices of rat cerebellum at different developmental stages.
Natriuretic peptides, such as atrial natriuretic peptide (ANP),
whose receptors also possess intrinsic guanylyl cyclase activity
(Cao and Yang, 2008), were examined as alternative agonists
for cGMP generation by oligodendrocytes. The positive out-
come of these studies spawned tests of the possibility that the
NO-cGMP pathway influences oligodendrocyte development.
Materials and Methods
Animals
This study used male Sprague-Dawley rats aged 3–63 days and 11–
14 day-old wild-type mice and mice deficient in endothelial NO
synthase (eNOS2/2), the day of birth being called day 1. Homozy-
gous eNOS2/2 mice (SV129 and C57BLK/6 background) were
bred in-house (donated by Dr. Adrian Hobbs). The wild-type mice
were SV129-C57BLK/6 F1 hybrids (Harlan UK Limited, Bicester,
UK). Timed pregnant mice used for tissue culture were the CD-1
strain (Charles River) and were donated by Prof. William D.
Richardson. All animal use was approved by the local (UCL) ethics
committee and was carried out strictly in accordance with the UK
Animals (Scientific Procedures) Act 1986.
Special Chemicals
1-Benzyl-3-(hydroxymethyl-2-furyl)indazole (YC-1), diethylammo-
nium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate (DEA/
NO), (Z)-1-[N-(3-ammoniopropyl)-N-(n-propyl)-amino]/NO (PAPA/
NO), (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-
ium-1,2-diolate (DETA/NO) and 5-cyclopropyl-2-{1-(2-fluoroben-
zyl)-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-4-ylamine (BAY41-
2272), were from Enzo Life Sciences (Exeter, UK); stock solutions
of NO donors were made up in 10 mM NaOH and kept on ice.
ANP, C-type natriuretic peptide (CNP), 8-Bromo-cGMP (8-Br-
cGMP), bicuculline, and isobutylmethylxanthine (IBMX) were from
Sigma-Aldrich (Dorset, UK); 1H-[1,2,4], oxadiazolo[4,3-a]quinoxa-
lin-1-one (ODQ), L-nitroarginine (L-NNA)), N-methyl-D-aspartate
(NMDA), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 2-amino-
5-phosphonopentanoic acid (AP5), and 2-[(1S,2S)-2-carboxycyclo-
propyl]-3-(9H-xanthen-9-yl)-D-alanine (LY341495) were from Toc-
ris Cookson (Bristol, UK); tetrodotoxin (TTX) was from Latoxan
Laboratories (Rosans, France); Vectastain elite ABC KIT was from
Vecto Labs Ltd (Peterborough, UK); 3,30-diaminobenzidine (DAB)
was from Sigma-Aldrich (Dorset, UK); Mayer’s haemalum was from
Raymond A Lamb Ltd (Eastbourne UK). Common laboratory
chemicals were from Sigma-Aldrich and BDH Merck Ltd (Poole,
Dorset, UK).
Brain Slices and Optic Nerves
Brain slice methods were as used previously (Southam et al., 1991).
Briefly, 400 mm thick sagittal cerebellar slices from 4- to 14-day-old
animals were cut using a McIlwain tissue chopper whereas a vibro-
slicer (Intracel 1000 plus; Intracel Ltd., Royston, UK) was used to
prepare 300 mm thick slices from older animals. Coronal slices of
brainstem (300 mm thickness) were cut at the level of 7th nerve
from 14-day-old rats using the vibroslicer. Optic nerves from rats
and mice were isolated and incubated in vitro as described
(Garthwaite et al., 2006). Brain slices or optic nerves from different
animals were randomized and allowed to recover for at least 1 h in
artificial CSF (aCSF) solution in flasks held in a shaking water bath
at 37C, before experiments began. The aCSF was composed of
(mM): NaCl (120) KCl (2), CaCl2 (2), NaHCO3 (26) KH2PO4
(1.18), MgSO4 (1.19), and glucose (11), continuously gassed with
95% O2 and 5% CO2. The Ca
21-free aCSF had a raised MgSO4
concentration (4.2 mM) and was supplemented with EGTA
(0.2 mM). Most experiments were carried out in the presence of the
general phosphodiesterase inhibitor IBMX (1 mM; 10 min preincu-
bation) and, when used, antagonists were added 10 min prior to
IBMX. Following treatment, brain slices or optic nerves were either
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fixed for immunohistochemistry or were inactivated in boiling tris-
HCl buffer (50 mM, pH 7.5) containing EDTA (4 mM) and
homogenized by sonication after which aliquots were removed for
measurement of protein (bicinchoninic acid method) and cGMP
(radioimmunoassay).
Immunohistochemistry
cGMP immunohistochemistry was performed on sister tissues to
those used for cGMP measurement. The specimens were fixed in
ice-cold, freshly-depolymerized paraformaldehyde (4%) in 0.1 M
phosphate buffer (pH 7.4) for 2 h and usually then processed for
frozen (10 mm) sectioning, cerebellar slices being cut in the sagittal
plane, brainstem slices in the coronal plane, and optic nerves, longi-
tudinally. Some optic nerves were processed for semi-thin sectioning,
for which they were embedded in Durcupan resin in such a way
that half of each nerve could be sectioned (1 mm) longitudinally and
the other half transversely (Garthwaite et al., 1999). Immunostaining
of frozen tissues was performed generally as described (Garthwaite
et al., 2006). Briefly, sections were brought to room temperature,
incubated for 10 min with tris-buffered saline containing 0.1%
triton-X-100 (TBST), pH 7.6, at room temperature, and then
blocked for 1 h with 10% normal donkey serum in TBST at 4C.
The sections were then incubated with a mixture of primary anti-
bodies in TBST overnight at 4C. After washing in TBST (3 3 5
min), sections were incubated with appropriate secondary antibodies
at room temperature for 1 h, washed (3 3 5 min) in TBST before
being mounted in Vectashield mounting medium containing the
nuclear stain 4’,6-diamidino-2-phenylindole (DAPI; Vector Labora-
tories, Peterborough, UK). In some experiments, TO-PRO-3
(1:50,000, 5 min; Invitrogen, Paisley, UK) was used instead of
DAPI. Resin-embedded, semi-thin sections were immunostained as
before (Garthwaite et al., 1999). Briefly, the sections were etched
with a 1:1 mixture of ethanol and saturated sodium hydroxide in
ethanol for 5 min at room temperature prior to incubation with pri-
mary antibodies against cGMP and CNPase (as below). Immunoper-
oxidase staining was carried out using rabbit biotinylated anti-sheep
antibody (Vector Laboratories; 1:1000, 1 h) followed by Vector stain
ABC elite (30 min) and then 3,30-diaminobenzidine (4 min) fol-
lowed by counterstaining in Mayer’s haemalum (5 min).
For nNOS and eNOS immunohistochemistry, the procedure
was as described above except that the tissues were fixed in 1% para-
formaldehyde. As controls for all the immunohistochemistry, the pri-
mary antibodies were omitted.
The primary antibodies and their sources were: sheep anti-
cGMP (a gift from Dr Jan de Vente, Maastricht, Netherlands;
1:1000); monoclonal mouse anti-20,30-cyclic nucleotide 30-
phosphodiesterase (CNPase; 1:2000) and monoclonal mouse anti-
myelin oligodendrocyte glycoprotein (MOG; 1:200), both from
Millipore (Watford, UK); mouse monoclonal anti-myelin basic pro-
tein (MBP; Serotec, Herts, UK; 1:100); polyclonal rabbit anti-glial
fibrillary acidic protein (GFAP; Sigma-Aldrich; 1:1000), polyclonal
rabbit anti-neuronal NO synthase (Zymed, San Francisco, CA, USA;
1:500), monoclonal mouse anti-endothelial NO synthase (BD Trans-
duction Laboratories, Lexington, KY, USA; 1:200); polyclonal rabbit
anti-neurofilament-68 (NF68; 1:1000), anti-neurofilament-200
(NF200; 1:1000), anti-NG2 (1:500), and anti-ANP (1:100) all from
Chemicon Europe (Hampshire, UK); rabbit anti-CNP peptide-22
(1:200) from Phoenix Pharmaceuticals Inc., Burlingame, CA, USA.
Secondary antibodies were: Alexa Fluor 488 donkey anti-sheep IgG
(1:1000), donkey anti-rabbit IgG (1:1000) and donkey anti-mouse
IgG (1:200); Alexa Fluor 568 donkey anti-mouse IgG (1:500) and
donkey anti-rabbit IgG (1:200); Alexa Fluor 594 donkey anti-mouse
IgG (1:500), donkey anti-rabbit (1:1000) and donkey anti-rat IgG
(1:500), all from Invitrogen; fluorescein-labeled donkey anti-sheep
and rhodamine-labeled donkey anti-mouse (1:200), both from
Chemicon. Images were captured in a confocal microscope (TCS-
DMRE-7 or SP1-DMRE-7, Leica, Milton Keynes, UK). The titres
of secondary antibodies were chosen from an initial series of double
dilutions within the range recommended by the manufacturer; lack
of bleed-through was verified using single-labeled sections.
Primary Cultures
Cultures from mouse E14.5 cerebral cortices were prepared using a
published method (Tekki-Kessaris et al., 2001) with minor modifica-
tions. Briefly, the cortices were dissected into ice-cold Earle’s buffered
saline solution (Gibco BRL, Paisley, UK) without Ca21 or Mg21
and then incubated in Earle’s buffered saline solution containing
trypsin (0.00625% w/v) and DNase I (13 mg/mL) at 37C for 40–
50 min. Digestion was halted by the addition of Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing 10% fetal bovine serum
and cells dissociated by tapping sharply on the bench 4–5 times.
The medium was removed and saved and the tapping process
repeated. The pooled media were centrifuged and the cells resus-
pended in a defined medium comprising DMEM supplemented
with transferrin (100 mg/mL), bovine serum albumin (100 mg/mL),
progesterone (20 nM), sodium selenite (30 nM), thyroxine
(400 ng/mL), triido-L-thyronine (300 ng/mL), putrescine (100 mM),
insulin (5 mg/mL), and human basic fibroblast growth factor (bFGF;
20 ng/mL) which stimulates the generation of oligodendrocyte pro-
genitor cells (Kessaris et al., 2004). The cells were then plated onto
glass coverslips pre-coated with poly-D-lysine (0.02 mg/mL) at a
density of 1.25 3 105 cells (0.35 mL) per well and incubated at
37C in a 5% CO2 incubator. Half of the medium was changed
every other day and bFGF was removed on day 3 post-plating. The
development of oligodendrocytes in the cultures was initially charac-
terized by fixation (ice-cold 4% paraformaldehyde for 40 min) fol-
lowed by immunolabeling for NG2, CNPase, MBP, and MOG.
Selected cultures were also immunostained for astrocytes (GFAP),
nNOS, and cGMP.
Image Analysis
For quantifying colocalization of cGMP with CNPase, MOG
or NF68 in cerebellar slices and optic nerve, confocal z-stacks
(0.75–1 mm) were acquired with the gain and offset being kept con-
stant. JACoP (Just Another Colocalisation Plugin) was used in
ImageJ to calculate the Manders’ M1 overlap coefficient on the aver-
age projection image generated from the z-stack (http://rsbweb.nih.
gov/ij/index.html). Colocalization of cGMP and CNPase in cortical
cultures was analyzed from z-stacks (1 mm apart) of fixed cells in
ImageJ. Binary images were first created using a set threshold (which
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remained the same for all images analyzed) and they were then com-
bined using the AND logic operator; the histogram function was used
to calculate the number of coinciding pixels that were above the thresh-
old in both red and green channels (Bolte and Cordelieres, 2006).
To analyze changes in oligodendrocyte morphology in cortical
cultures, confocal images at low magnification (16X) were captured
from five fields (each measuring 1 mm2) per coverslip. The fields
were chosen as follows: imaginary axes were drawn through the
centre of the coverslip at right angles to each other. The first image
was taken from the centre and the other four were two fields away
on each axis. The images were transferred to a computer and quanti-
fied in a blinded manner by two independent observers. The areas
occupied by the oligodendrocyte processes were demarcated with
circles and the cells arbitrarily divided into two groups having overall
diameters below and above 70 mm. The percentage of cells with
diameter above 70 mm was then calculated for each experimental
condition. In selected conditions, the exact diameters of oligoden-
drocytes wider than 70 mm were measured in five areas of each cov-
erslip, selected as described above.
To quantify oligodendrocyte cGMP accumulation in optic
nerves from 7-day-old rats, confocal images were taken from the
middle and 100 mm from each end (chiasmatic and global) of each
of three longitudinal sections per nerve (100 mm or more apart).
Counts of total CNPase-positive cell bodies with and without cGMP
staining were performed on multiple 400 3 400 mm fields in a
blinded fashion by two independent observers. Only those CNPase-
stained cells showing complete cytoplasmic fluorescence were scored
as CNPase-positive cells.
Modeling NO Concentrations
NO concentrations in the tissue-culture medium resulting from
release of NO from DETA/NO were calculated by solving the fol-
lowing pair of differential equations in Mathcad 14 (Parametric
Technology Corp., Needham, MA, USA):
dDETA=NOðtÞ
dt
52k1DETA=NOðtÞ;
dNOðtÞ
dt
5nk1DETA=NOðtÞ2k2O2NOðtÞ22koutNOðtÞ;
where k15 rate constant for DETA/NO decomposition (9.627 3
1026 s21 for a 20 h half-life), k25 autoxidation rate constant (1.36
3 107 M22 s21; Schmidt et al., 1997), n is the stoichiometry of
NO release from DETA/NO (assumed to be 2; Mooradian et al.,
1995), O25 oxygen concentration (0.21 mM for an air-equilibrated
solution), and kout is the rate constant for loss of NO by mass trans-
fer into the atmosphere. When NO is generated within a tissue-
culture dish, the atmosphere immediately above the medium is likely
to be effectively NO-free and mass transfer into this phase will rep-
resent a significant loss of NO from the medium during longer
experiments (Chen and Deen, 2001). Having limited water solubil-
ity, mass transfer of NO will be governed almost entirely by its rate
of exit from the aqueous phase, so that kout5 kL(A/V), where kL is
the liquid mass transfer coefficient, which was taken to be the value
for O2 mid-way between values for minimally-agitated samples of
distilled water and sea-water saline at 37C, that is, 5.6 3 1024 cm s21
(Downing and Truesdale, 1955); A5 area of medium exposed to the
atmosphere (1.327 cm2 for a 1.3 cm diameter tissue-culture well)
and V5 volume of medium (0.35 cm3). Using these values,
kout5 2.124 3 10
23 s21. Cellular mechanisms that consume NO
may also be present (Griffiths and Garthwaite, 2001), so the NO
concentrations calculated in this way could be overestimates.
Statistics
Values are presented as means6 SEM; statistical analysis used one-
way ANOVA; a P value of <0.05 was considered significant.
Results
The general strategy initially was to examine the cellular loca-
tion of cGMP using immunocytochemistry in and around
the white matter of cerebellar slices after stimulation with
exogenous or endogenous NO. Exogenous NO was usually
supplied by PAPA/NO at a concentration (30 mM) giving
half-maximal or maximal cGMP accumulation in rat optic
nerve depending on age (see below). To discern the targets of
endogenous NO, the slices were exposed to BAY 41-2272 or
YC-1, these being allosteric enhancers of NO-activated gua-
nylyl cyclase (Evgenov et al., 2006; Roy et al., 2008) able to
amplify endogenous NO-stimulated cGMP accumulation into
the range that is detectable immunocytochemically (Bartus
et al., 2013; Garthwaite et al., 2006). The other main stimuli
applied to the slices were ANP, which activates a transmem-
brane guanylyl cyclase-coupled receptor (Cao and Yang,
2008), and the glutamate agonist NMDA whose receptors,
when stimulated, couple to nNOS activation (Garthwaite,
2008). The NMDA concentration chosen (30 mM) gives
approximately half-maximal cGMP accumulation in cerebellar
slices from the developing rat (Garthwaite, 1985) and the
ANP concentration (1 mM) yields a maximal cGMP response
from adult guinea-pig cerebellar slices (Hernandez et al.,
1994) or rat optic nerve (see below). Immunostaining for
CNPase was routinely used to identify oligodendrocytes.
cGMP Accumulation in Oligodendrocytes During
Cerebellar Development
In slices of 3-day-old rat cerebellum incubated with the gen-
eral phosphodiesterase inhibitor IBMX (1 mM), PAPA/NO,
BAY 41-2272, ANP, and NMDA all evoked cGMP immuno-
staining of putative astrocytes but CNPase-positive oligoden-
drocytes were unstained (Fig. 1A–D).
With tissue from 8- to 10-day-old animals, little or no
cGMP immunolabeling was apparent under basal conditions,
when only IBMX (1 mM) was present (Fig. 2A). With the
further addition of PAPA/NO, cGMP immunoreactivity was
seen over the majority of oligodendrocytes (Fig. 2C). This
response was inhibited by 10 mM ODQ (Fig. 2D), a com-
pound that blocks the activation of guanylyl cyclase by NO
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(Garthwaite et al., 1995). To test more rigorously for colocali-
zation, the tissue was immunostained for cGMP along with
CNPase, or MOG, a marker for mature oligodendrocytes, or
NF68, an axonal marker. The orthogonal projections showed
colocalized immunostaining between cGMP, CNPase, and
MOG, but not between cGMP and NF68 (Fig. 3A–C). The
FIGURE 2: NO and ANP stimulate cGMP accumulation in oligodendrocytes in 8- to 9-day-old rat cerebellar slices. The immunohistochem-
ical images (A–F) are all overlayed (see A for color code; yellow indicates coincident cGMP and CNPase staining). Conditions are given
at the top of each panel (PAPA/NO, 30 lM, 5 min; ANP, 1 lM, 10 min; NMDA, 30 lM, 2 min). When present, ODQ and IBMX concentra-
tions were at 10 lM and 1 mM, respectively. Key: DCN, deep cerebellar nucleus; Bg, Bergmann glia; igl, internal granule cell layer; wm,
white matter; arrows, oligodendrocytes; arrowheads, putative astrocytes. Pictures are representative of 6–8 slices from 2–3 different
experiments. Scale bar (in A)525 lm (applies to all panels). (G) cGMP levels in slices measured in parallel by radioimmunoassay (n56–
12 from 2–3 separate experiments). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 1: Lack of oligodendrocyte cGMP immunostaining in 3-day-old rat cerebellar slices. Sections show the primitive white matter
(wm) in slices previously exposed to (A) PAPA/NO (30 lM, 5 min), (B) BAY 41-2272 (3 lM, 5 min), (C) ANP (1 lM, 10 min), and (D)
NMDA (30 lM, 2 min), all in the presence of IBMX (1 mM). Sections were stained for CNPase (red), cGMP (green) and nuclei (DAPI,
blue) and the images overlayed. Key: arrows, CNPase-positive oligodendrocytes; arrowheads, putative astrocytes; igl, internal granule
cell layer. Images are representative of 4–5 slices in two experiments. Scale bar (A) 513 lm. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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conclusion from these results, namely that cGMP immuno-
staining was in oligodendrocytes and not in axons, was veri-
fied by a colocalization analysis (Fig. 3D).
Without IBMX, only very few oligodendrocytes generated
detectable cGMP immunostaining in response to PAPA/NO
(Fig. 2B), suggesting that phosphodiesterase enzymes actively
suppress NO-stimulated cGMP accumulation in this cell type.
By contrast, putative astrocytes were cGMP-positive with or
without IBMX (Fig. 2B,C), consistent with cerebellar astrocytes
having only low cGMP-hydrolyzing phosphodiesterase activity
(Bellamy and Garthwaite, 2001). With IBMX included, ANP
(in the presence of ODQ) also caused extensive cGMP accumu-
lation in oligodendrocytes (Fig. 2E). Moreover, NMDA pro-
voked robust oligodendrocyte cGMP accumulation, but only in
those regions of the white matter adjacent to the internal granule
cell layer (Fig. 2F), this being a layer rich in neurones expressing
nNOS and NMDA receptors (Contestabile, 2012; Moriyoshi
et al., 1991). Measurements made in three sections (two experi-
ments) in which the white matter was sufficiently wide (>100
mm) indicated that the cGMP immunostaining diminished pro-
gressively with distance from the internal granule cell layer into
the white matter, to be just detectable 306 4 mm away.
In parallel, cGMP in the slices was measured directly by
radioimmunoassay (Fig. 2G). Inclusion of IBMX raised
cGMP levels from near zero to approximately 40 pmol/mg
protein although this condition gave only faint immunostain-
ing of some putative astrocytes (Fig. 2A). PAPA/NO elevated
cGMP much further, to about 400 pmol/mg protein. The
response to PAPA/NO was more than doubled in the pres-
ence of IBMX and was inhibited almost completely by
ODQ. ANP (in the presence of IBMX) also elevated cGMP
to high levels (about 300 pmol/mg protein) both in the
absence and presence of ODQ (Fig. 2G).
To determine if these findings using exogenous NO
are relevant to endogenous NO signaling, slices were
exposed to the allosteric enhancers of NO-activated guanylyl
cyclase, BAY 41-2272 (3 mM) and YC-1 (50 mM). In the
absence of IBMX, incubation with BAY 41-2272 led to
marked cGMP immunostaining of putative astrocytes but
only occasionally of oligodendrocytes (Fig. 4A). With IBMX
present, almost all oligodendrocytes accumulated cGMP
(Fig. 4B), and this response was abolished by the NO syn-
thase inhibitor, L-nitroarginine (Fig. 4C). Some (but not
all) GFAP-positive astrocytes in the white matter were also
cGMP-positive following incubation with IBMX plus BAY
41-2272 (Fig. 4D). Similarly to BAY 41-2272, the weaker
allosteric enhancer YC-1 also stimulated oligodendrocyte
cGMP accumulation (Fig. 4E) and this response was elimi-
nated by L-nitroarginine (Fig. 4F). The corresponding cere-
bellar slice cGMP measurements are included in a later
figure (see Fig. 8D).
The only previous study of this type had indicated that
corpus callosal oligodendrocyte cGMP accumulation in
response to NO is only transient during development, being
most evident in the 2-week-old rat and declining thereafter
(Tanaka et al., 1997). To examine the applicability of this
result to the cerebellum, oligodendrocytes in slices from
3-week-old and adult (6-weeks-old) rats were tested for sensi-
tivity to exogenous and endogenous NO, as well as to ANP.
The adult tissue responded similarly to the slices from imma-
ture (8- to 10-day-old) animals described above. In brief,
exposure to PAPA/NO caused cGMP immunostaining of oli-
godendrocytes located in the white matter and also within the
internal granule cell layer (Fig. 5A). BAY 41-2272 generated
a similar profile of cGMP immunostaining (Fig. 5B) that was
abolished by L-nitroarginine (Fig. 5C). ANP (in the presence
FIGURE 3: Colocalization analysis of cGMP immunoreactivity in the white matter of 10-day-old rat cerebellar slices. The slices were
exposed to PAPA/NO (30 lM, 5 min) in the presence of IBMX (1 mM) and sections stained for cGMP together with CNPase, MOG, or
NF68. (A–C) overlayed images of the x-y and corresponding orthogonal projections (z) at the level of the cross-hairs. Merged structures
appear yellow. The images were prepared from confocal z-stacks taken at 1 lm intervals. The results are representative of three slices
in two different experiments. Arrows, oligodendrocytes; arrowheads, axons in longitudinal (A, B) and cross-sectional (C) profiles. Scale
bar (A)525 lm (applies to all images). The histogram (D) shows mean values (6SEM) of the Manders’ M1 colocalization coefficient
determined from an area of 0.32 mm2 in each section; a value of 1.0 signifies 100% colocalization. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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of L-nitroarginine) also evoked cGMP accumulation in oligo-
dendrocytes in white and grey matter (Fig. 5D), as did
NMDA (Fig. 5E). Strong cGMP immunoreactivity in Berg-
mann glia and other cells presumed to be astrocytes was also
observed with PAPA/NO, BAY 41-2272 (without L-nitroargi-
nine), ANP, and NMDA. Enlargements from Fig. 5 are in
FIGURE 4: Endogenous NO targets oligodendrocytes in 8- to 9-day-old rat cerebellar slices. The slices were exposed for 5 min to BAY
41-2272 (3 lM, 5 min; A–D) or YC-1 (50 lM, 5 min; E, F) in the absence (A) or presence (B–F) of IBMX (1 mM). Cryostat sections were
immunostained for cGMP (green) together with CNPase (red; A–C, E, F) or GFAP (red; D). Images are all overlays in which green/red co-
staining appears yellow. Nuclei are stained with DAPI (blue). The cGMP immunostaining was abolished by L-nitroarginine (L-NNA, 100
lM; C, F). Key: arrows, oligodendrocytes; arrowheads, GFAP-positive astrocytes (D) and putative astrocytes (A, B, E); wm, white matter;
igl, internal granule cell layer; P, Purkinje cell; Bg, Bergmann glia. Images are representative of 4–6 slices from two experiments. Scale
bar (A)525 lm (applies to all panels). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 5: Targeting of oligodendrocytes in slices of adult rat cerebellum by exogenous and endogenous NO. Slices were stimulated by
(A) PAPA/NO (30 lM, 5 min), (B, C) BAY 41-2272 (3 lM, 5 min), (D) ANP (1 lM, 10 min) or (E) NMDA (30 lM, 2 min) all in the presence
of IBMX (1 mM). L-nitroarginine (L-NNA, 100 lM) was present in C and D. Sections were stained for cGMP (green), CNPase (red) and
DAPI (blue). Images are all overlays (red/green co-staining appears yellow) and are representative of six slices per condition in two
experiments. Key: ml, molecular layer; P, Purkinje cell; Bg, Bergmann glia; gcl, granule cell layer, wm5white matter; arrows, oligoden-
drocytes; arrowheads, putative astrocytes. Scale bar (A)550 lm (applies to all panels). [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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Supporting Information Fig. S1. The results using 3-week-old
rat cerebellar slices subjected to PAPA/NO were closely com-
parable to those from the adult (not illustrated).
Sites of NO-Stimulated cGMP Accumulation in Rat
Brainstem Slices
As a partial test of the generality of the above findings,
experiments were carried out on white matter-rich slices of
brainstem from 14-day-old rats. Most of the oligodendrocytes
accumulated cGMP in response to exogenous NO (this time
donated by DEA/NO) and, conversely, most of the cGMP
immunoreactivity was associated with oligodendrocytes (Fig.
6A–C).
NO- and Natriuretic Peptide-Stimulated cGMP
Accumulation in Rat Optic Nerve
We previously reported that, in the adult and immature rat
optic nerve, macroglia (which include oligodendrocytes) did
not appear to accumulate cGMP on exposure to NO, whereas
axons became strongly cGMP-positive (Garthwaite et al.,
1999, 2006). Considering the divergent findings from both
cerebellum and brainstem reported above, we sought to re-
examine the responsiveness of optic nerve oligodendrocytes to
NO and to test the possibility that their cGMP content may
be regulated by natriuretic peptides instead.
When 10-day-old or adult rat optic nerves were incu-
bated with either PAPA/NO or ANP (both in the presence of
IBMX), cGMP levels became elevated in a concentration-
dependent manner (Fig. 7A,B). The related peptide CNP also
gave concentration-dependent increases of cGMP in 10-day-
old rat nerves (Fig. 7C; adult nerves were not tested).
Responses to NO, but not those to ANP or CNP, were inhib-
ited by ODQ (Fig. 7A–C). Immunohistochemistry in 10-
day-old nerves showed that PAPA/NO caused cGMP accu-
mulation in axons whereas ANP and CNP appeared only to
generate a response from oligodendrocytes (Fig. 7C–E). In
accordance with this conclusion, after incubation with ANP,
cGMP was strongly colocalized with either MOG or CNPase,
as shown by quantitative analysis (Fig. 7F). The selective
responsiveness of oligodendrocytes to ANP was also seen in
the adult (Fig. 7I,J) in which additional immunostaining of
presumed myelin sheaths could also be detected (Fig. 7J,K).
In contrast, as in the 10-day-old optic nerves, PAPA/NO-
evoked cGMP accumulation appeared in axons but not in oli-
godendrocytes (Fig. 7G) nor in myelin sheaths (Fig. 7H).
Optic nerves from animals as young as 1-day-old
responded to PAPA/NO or BAY 41-2272 with axonal cGMP
accumulation whereas, with ANP, only a few CNPase-positive
oligodendrocytes in the 7-day-old tissue exhibited faint
cGMP immunostaining (26 0.33%; n5 3 nerves from dif-
ferent animals), with no significant variation with position
along the nerve (P> 0.05 by ANOVA). At this age, oligoden-
drocytes did not stain detectably for MOG and there was
very limited MBP immunostaining. In the 3-day-old tissue,
CNPase-positive cells were observed only in the chiasm but
no cGMP immunostaining of these cells (or of the abundant
NG2-positive cells) after exposure to ANP was observed
(Supp. Info. Fig. S2).
Sources of Endogenous Agonists Generating cGMP
in Cerebellar Oligodendrocytes
The two constitutive NO synthases, eNOS and nNOS,
showed a differential distribution in the developing rat cere-
bellum, eNOS being confined to blood vessels and nNOS
being expressed in granule cells in the internal granule cell
layer and in the molecular layer (Fig. 8A), where it is primar-
ily located in inhibitory interneurones (Bredt et al., 1990;
Wood et al., 2011). As NO synthase inhibitors able to
FIGURE 6: NO stimulates cGMP accumulation in oligodendrocytes in slices of 14-day-old rat brainstem. The slices were exposed to
DEA/NO (100 lM, 5 min) in the presence of IBMX (1 mM). Images are from coronal sections at the level of the XII nerve, stained for (A)
CNPase (red), (B) cGMP (green) and DAPI (blue). (C) overlay of A and B. Key: broken line, the mid line; py, pyramid; wm, white matter;
arrows, oligodendrocytes. Insets are enlargements centred on the two arrowed cells near the midline. Scale (A)550 lm or 25 lm
(insets). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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FIGURE 7: Differential targeting of axons and oligodendrocytes by NO and natriuretic peptides in rat optic nerve. (A–C) Concentration-
cGMP response curves to PAPA/NO (A, 5 min), ANP (B, 10 min) and CNP (C, 10 min) in 10-day-old (red) or adult (blue) optic nerves in
the absence (filled symbols) or presence (open symbols) of 10 lM ODQ (n55–9 nerves from 2–4 separate experiments). Insets in C:
CNPase, cGMP and overlayed immunostaining in a nerve exposed to 1 lM CNP (10 min); arrows indicate a pair of the co-stained cells
(yellow). (D, E) 10-day-old rat optic nerves exposed to PAPA/NO (30 lM, 5 min, D) or ANP (1 lM, 10 min, E) and stained for cGMP
together with the axonal marker NF-200 (D) or the oligodendrocyte marker MOG (E). The main panels are overlays; fields of separate
images from the boxed regions are in the insets. Key: arrowhead, axons; asterisk, band of macroglia; arrow, oligodendrocyte. (F) Man-
ders’ coefficient of colocalization between MOG and cGMP or CNPase and cGMP in the absence and presence of ANP (data from 3
nerves). (G–K) Semithin sections from adult optic nerve exposed to PAPA/NO (G, H) or ANP (I–K) in longitudinal (G, I) and transverse (H,
J, K) planes. Panels G, H, J and K are immunoperoxidase staining for cGMP with haemalum counterstain. In G: asterisk, band of
unstained macroglia. In G and H: arrowheads, cGMP-positive axons. In I: filled arrow, oligodendrocyte; arrowhead, presumed fibrous
astrocyte; open arrow, myelinated axons. In J: black arrow, oligodendrocyte; red arrow, stained myelin (brown) surrounding an
unstained axon. In panel K, the primary antibody was omitted. In all experiments, the nerves were incubated with IBMX (1 mM); micro-
scopic images are representative of 4–6 nerves in 2–3 separate experiments. Nuclei (blue) were stained with DAPI (C, I) or TO-PRO (E).
Scale bar (in D)520 lm (in D), 29 lm (E), 10.5 lm (G, H), 9 lm (I) and 7.5 lm (J, K). [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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FIGURE 8: Sources of endogenous agonists acting to increase cGMP in oligodendrocytes in cerebellum. (A) Section from 10-day-old rat cer-
ebellar slice stained for eNOS (red), nNOS (green), and nuclei (DAPI, blue). (B) Section of a slice from a 14-day-old eNOS2/2 mouse incu-
bated with BAY 41-2272 (3 lM; 5 min) and stained for CNPase (red) and cGMP (green), showing cGMP accumulation in oligodendrocytes
(examples arrowed). Asterisk indicates non-specific staining of blood vessel (staining persisted after omission of primary antibody). (C)
cGMP radioimmunoassay measurements in slices of wild-type (WT) and eNOS2/2 mouse cerebellum showing responses to BAY41-2272
(red bars) in the absence and presence of L-nitroarginine (L-NNA, 100 lM) and of a mixture of antagonists (“antags,” blue bars) of iono-
tropic glutamate receptors (100 lM AP5 plus 100 lM CNQX) and of Na1 channels (1 lM TTX). Data are from 6–9 slices in three separate
experiments; the population means were not significantly different from each other (P>0.05 by one-way ANOVA). (D) Cerebellar slices
from 10-day-old rats exposed for 5 min to BAY41-2272 (BAY 41; 3 lM, left columns) or YC-1 (50 lM, right columns) under the indicated con-
ditions. The concentrations of AP5, CNQX, TTX and L-NNA were as given above; ODQ was at 10 lM and the general metabotropic gluta-
mate receptor blocker LY341495 was at 100 lM; n54-12 (2–5 separate experiments). (E, F) Sections of 10-day-old (E) and 6-week-old (F)
rat cerebellar slices exposed to BAY 41-2272 (3 lM, 5 min) in the presence of a mixture of AP5, CNQX and TTX (“antags”), immunostained
for cGMP (green) and CNPase (red). (G, H) Immunostained sections of 10-day-old rat cerebellar slices exposed to BAY 41-2272 (5 lM, 5
min) in the presence (G) or absence (H) of Ca21. (I) cGMP levels in the absence (open columns) and presence (red columns) of BAY 41-2272
(3 lM; 5 min) under control and Ca21-free conditions (as indicated); n57–9 (three separate experiments). IBMX (1 mM) was present
throughout. (J) Images from a 10-day-old rat cerebellar slice immunostained for ANP and/or eNOS as indicated; nuclei are stained with TO-
PRO (blue). In the micrographs, arrows point to oligodendrocytes and arrowheads signify putative astrocytes. Key: egl, external granule
cell layer; igl, internal granule cell layer; gcl, granule cell layer; ml, molecular layer; Bg, Bergmann glia; wm, white matter. Scale bar (in
A)5100 lm (A); 35 lm (B): 26 lm (E); 50 lm (F, J) and 80 lm (G, H). All images are representative of four slices in two separate experiments.
Histogram results (C, D, I) are means6SEM. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
distinguish between the two isoforms experimentally in intact
cells and tissues are still lacking (Pigott et al., 2013), cGMP
immunostaining was applied to cerebellar slices from wild-
type mice and mice deficient in eNOS. On exposure to BAY
41-2272, the staining was indistinguishable, with cGMP
being found in oligodendrocytes as well as in Bergmann glia
and other presumed astrocytes (Fig. 8B), as found in the rat
tissue. cGMP levels in the presence of BAY 41-2272 were not
significantly altered in slices from eNOS knockouts but, as in
the wild-type tissue, they were sensitive to inhibition by L-
nitroarginine (Fig. 8C), confirming that they were sustained
by NO synthase activity.
The lack of obvious participation of eNOS in the
basal NO tone of the tissue differs from findings made on
optic nerve (Garthwaite et al., 2006). Given this apparent
disparity, the previous result was reexamined using optic
nerves from 11-day-old mice. Nerves from wild-type mice
exposed to BAY 41-2272 (3 mM, 5 min, in the presence of
1 mM IBMX) produced 1356 18 pmol cGMP/mg protein
whereas nerves from eNOS knockouts gave only 136 5
pmol cGMP/mg protein (n5 6 nerves from two experi-
ments). This result compares well with that reported previ-
ously (Garthwaite et al., 2006), indicating that the tissue
differences with respect to the participation of eNOS in
basal NO levels are real.
The findings with eNOS-knockout mice suggest that
nNOS is the main candidate enzyme responsible for basal NO
in the cerebellum. nNOS typically becomes active in response
to stimulation of NMDA receptors, although non-NMDA
receptors could, in principle, also participate (Southam et al.,
1991). When slices were exposed to BAY 41-2272, cGMP lev-
els in either wild-type or eNOS-knockout tissues were unaf-
fected by a mixture of antagonists for NMDA and non-
NMDA receptors (AP51CNQX), together with a blocker of
voltage-gated Na1 channels (TTX) to inhibit action potential-
dependent network activity (Fig. 8C). Similarly, in slices from
the 10-day-old rat exposed to BAY 41-2272, cGMP levels were
unaffected by AP5 plus CNQX, or TTX, or an inhibitor of
metabotropic glutamate receptors (LY 341495) at a concentra-
tion (100 mM) high enough to act without subtype selectively
(Kingston et al., 1998) (Fig. 8D). In accordance with these
results, oligodendrocyte cGMP immunostaining persisted in
slices of both the 10-day-old and adult rat cerebellum exposed
to BAY 41-2272 in the combined presence of AP5, CNQX,
and TTX (Fig. 8E,F).
As GABA may raise cerebellar cGMP (Ferrendelli et al.,
1974), the GABAA antagonist bicuculline (30 mM) was also
tested but found to have no significant effect: cGMP levels
were 3416 36 pmol/mg protein in the control slices exposed
to BAY 41-2272 (1 mM) and 2416 25 with bicuculline addi-
tionally included (n5 4–5; P> 0.05). As expected for nNOS,
the cGMP immunostaining and elevation in cGMP levels
were virtually abolished when the slices were incubated under
Ca21-free conditions (Fig. 8G–I), a result that also eliminates
from consideration the Ca21-independent inducible NO syn-
thase isoform (Cho et al., 1992).
Possible endogenous sources of ANP in the 10-day-old
rat cerebellum were also investigated. ANP immunostaining
coincided with eNOS (Fig. 8J), implying that the peptide is
present and is mainly located in blood vessels in the develop-
ing tissue. In the 10-day-old rat optic nerve, ANP immuno-
staining also colocalized with eNOS and the distribution of
CNP immunolabeling likewise suggested that this peptide is
mainly present in blood vessels (Supp. Info. Fig. S3).
Oligodendrocytes as NO Targets in Cortical
Cultures: Developmental Characterization
We speculated from the ontogenesis of cGMP accumulation
in cerebellar oligodendrocytes in response to NO and ANP
that cGMP might have a physiological role in oligodendro-
cyte maturation. Experiments were carried out to determine
the suitability of cultures derived from embryonic mouse cer-
ebral cortex for this purpose.
Early on (3 days after seeding) many cells stained posi-
tively for NG2, a marker of oligodendrocyte precursor cells,
with only the occasional cell showing faint staining for
CNPase, an early-appearing marker of oligodendrocyte differ-
entiation (Fig. 9A). There were also a few cells that stained
faintly for nNOS, while none stained for the astrocytic
marker GFAP (Fig. 9B). At 6 days in vitro (DIV), distinct
CNPase-positive cells appeared, some of which co-stained for
MBP, a marker for more mature oligodendrocytes (Fig. 9C).
At this stage, some cells expressed MOG, a marker of mature
oligodendrocytes (Fig. 9D) and GFAP-positive cells were eas-
ily recognizable (Fig. 9D). nNOS-positive cells and their
processes stained robustly (Fig. 9E), although they were small
in number, accounting for 36 0.7% of the total cell popula-
tion (from four coverslips in two experiments).
At 17 DIV, NG2-positive cells with preoligodendrocyte
morphology were still present (Fig. 9F), together with cells
staining for CNPase, MOG, and MBP (see below). Cultures
at this age were selected to test for responsiveness to exoge-
nous and endogenous NO. Two different NO donors, PAPA/
NO (30 mM, 2 min) and DEA/NO (100 nM, 2 min) elicited
cGMP immunostaining in MOG-positive (Fig. 9G,H) and
CNPase-positive oligodendrocytes as shown by quantitative
image analysis (Fig. 9L). Incubation with BAY 41-2272 (1
mM) also resulted in cGMP accumulation in CNPase-positive
oligodendrocytes (Fig. 9J,L), a response that was blocked by
L-nitroarginine (Fig. 9K,L). The combination of DEA/NO
and BAY 41-2272 increased oligodendrocyte cGMP more
than each stimulant alone (Fig. 9I,L).
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Effects of the NO-cGMP Pathway on
Oligodendrocyte Arborization
Having established that the cultured cortical oligodendrocytes
resembled their counterparts in cerebellar and brainstem slices
in being NO targets, experiments were carried out to deter-
mine if this signaling pathway affected their morphological
development. For this purpose, the cultures were immuno-
stained for CNPase and MBP. Under all conditions tested,
some cells at 8 DIV stained only for CNPase but more of
them stained for both markers (Fig. 10A,B,D–F,L), signifying
a more advanced maturational state. The majority of oligo-
dendrocytes in untreated cultures had limited arborization
(Fig. 10A).
To quantify the extent of arborization, we adopted a
simple yardstick (see Materials and Methods) whereby a circle
was used to circumscribe the territory of each oligodendrocyte
(see Fig. 10H,I) and the numbers of cells whose territorial
diameter was greater than a particular value, arbitrarily chosen
as 70 mm, were counted (Fig. 10J). The controls had
286 2% of oligodendrocytes meeting this criterion (from
eight coverslips in four experiments). In an attempt to emu-
late endogenous NO production, cultures were exposed from
3 DIV to 8 DIV (when they were fixed) to low concentra-
tions of DETA/NO (3 and 10 nM), a donor that has a long
half-life (20 h) and so releases NO very slowly (initially 3
and 10 pM per min, respectively). With 3 nM DETA/NO,
FIGURE 9: Differentiation of oligodendrocytes in cortical cultures and their responsiveness to exogenous and endogenous NO. (A–F) Cultures at
3 DIV (A, B), 6 DIV (C–E), and 17 DIV (F) immunostained for the indicated markers. Arrows point to examples of CNPase-positive oligodendro-
cytes (A), nNOS-positive cells (B, E), CNPase-positive and/or MBP-positive oligodendrocytes (C), MOG-positive oligodendrocytes (D), and NG2-
positive cells (F); arrowheads, examples of GFAP-positive astrocytes (D, F). Scale bar (in A)540 lm (for A, C–F) and 29 lm (B). (G–K) cGMP immu-
nostaining (green) in oligodendrocyes (red) immunolabeled with CNPase or MOG at 17 DIV following exposure to PAPA/NO (30 lM, 2 min; G),
DEA/NO (100 nM, 2 min; H, I) and/or BAY 41-2272 (1 lM, 7 min; I–K) in the absence (J) or presence (K) of L-nitroarginine (L-NNA, 100 lM), all in
the presence of IBMX (1 mM). Arrows, cGMP-positive (G–J) or negative (K) oligodendrocytes; arrowheads, examples of cGMP-positive putative
astrocytes (I, J). Scale bar (G)540 lm (for G–K). (L) Numbers of pixels containing both red (CNPase) and green (cGMP) signals derived from z-
stacks (1 lm) of 0.17 mm2 images of cultures under the indicated conditions (concentrations and exposure periods as above); data are mean-
s6SEM from three coverslips in two experiments. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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no significant morphological effects were seen (Fig. 10B,J). At
10 nM DETA/NO, however, there was a marked increase in
the spread of the oligodendrocyte arbor (Fig. 10E,I) that was
reflected in a 2.2-fold increase in the number of cells with
territorial diameters exceeding 70 mm (Fig. 10J). This increase
appeared to represent a general shift in the population to
larger sizes because the mean territorial diameter of cells >70
mm increased by 67% (Fig. 10K).
BAY 41-2272 (1 lM) on its own had a relatively
smaller, but significant, effect on the proportion of larger oli-
godendrocytes (Fig. 10C,J) and also increased their mean size
(Fig. 10K). When BAY 41-2272 was combined with the nor-
mally subthreshold concentration of DETA/NO (3 nM), the
percentage of large oligodendrocytes became similar to that
found at the higher DETA/NO concentration (Fig. 10D,J).
Adding BAY 41-2272 to the higher DETA/NO concentration
(10 nM) gave no significant further increase in oligodendro-
cyte spread (Fig. 10J), suggesting that this DETA/NO con-
centration on its own was maximal. The ability of BAY 41-
2272 to enhance the response to the low DETA/NO concen-
tration provides good evidence that NO-activated guanylyl
cyclase is the downstream effector. In aiming to further test
this possibility, ODQ was initially used but it was found to
be toxic to the cells during prolonged exposure, in common
with findings made on other cultures (Haramis et al., 2008).
As an alternative approach, the membrane-permeating cGMP
FIGURE 10: Effect of NO-cGMP signaling on the morphological differentiation of cultured oligodendrocytes. Cultures were exposed to the
stated conditions from 3 DIV (A–K) or 6 DIV (L) and fixed at 8 DIV. Oligodendrocytes (examples arrowed) were immunolabeled for CNPase and
MBP (A, B, D–F, L) or for CNPase alone (C, H, I); nuclei were stained with TO-PRO or DAPI as indicated. Primary antibodies were omitted in the
control (G). The method used to quantify the spread of oligodendrocytes is illustrated in H and I, where the red circles demarcate territories of
70 lm or less in diameter and yellow circles, territories above this value. The histograms show the percentage of cells >70 lm in diameter (J) and
their mean diameter (K) under selected conditions; data are means6SEM from five areas (each 1 mm2) per coverslip and 3–8 coverslips in 2–3
experiments. In J, *significantly different from basal (P<0.05); ** significantly different from basal and from BAY 41-2272 alone (P<0.05) but not
from each other; in K, *significantly different from basal (P<0.05) but not from each other (one-way ANOVA). Micrographs are representative
illustrations from the same experiments. Key: BAY 41, BAY 41-2272; DETA (in J), DETA/NO. Scale bar (in A)540 lm (for A–G, L); scale bar (in
H)550 lm (for H, I). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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analogue, 8-bromo-cGMP was applied (from 3 DIV
onwards). At 10 nM, 8-bromo-cGMP had no significant
effect but higher concentrations led to a progressively increas-
ing proportion of large oligodendrocytes (Fig. 10F), the half-
maximal effect occurring at <100 nM and a maximum
change (at 1–10 mM) that was comparable with that found
after exposure to 10 nM DETA/NO (Fig. 10J). The mean
size of the larger oligodendrocyte population in the presence
of 100 nM 8-Br-cGMP increased by an amount similar to
that found with 10 nM DETA/NO (Fig. 10K).
Although the duration of the exposures used above was
for several days, the combination of DETA/NO (10 nM)
plus BAY 41-2272 added at 6 DIV was found to have a simi-
lar effect to when it was applied 3 days earlier (Fig. 10L),
indicating that the more prolonged (6 days) exposure is not
required to bring about the observed morphological develop-
ment of oligodendrocytes.
Discussion
The results indicate that oligodendrocytes in the rat cerebel-
lum are physiological targets for neuronally-derived NO from
early postnatal development into adulthood, that responsive-
ness to NO (exhibited as cGMP accumulation) may be a
widespread property of oligodendrocytes, that ANP or CNP
can provide alternative signals for oligodendrocyte cGMP
accumulation, and that a downstream consequence of this sig-
naling pathway is enhanced morphological development.
There had previously been scant evidence for consider-
ing oligodendrocytes as recipients of physiological NO sig-
nals. In the developing and adult cerebellum, use of cGMP
immunocytochemistry had highlighted astrocytes in white
and grey matter (de Vente et al., 1990) but no attempt was
made to determine if oligodendrocytes might also be NO- or
ANP-responsive. In the only directly relevant study, it was
found that NO raised cGMP in oligodendrocytes in the cor-
pus callosum of 2-week-old rats and that this responsiveness
declined with age thereafter (Tanaka et al., 1997). The same
study noted that ANP was unable to elicit detectable cGMP
accumulation in oligodendrocytes at the age when they dis-
played NO-responsiveness. In a separate investigation on rat
whole-brain spheroid cultures, occasional oligodendrocytes
were found to accumulate cGMP in response to sodium
nitroprusside, which releases NO (amongst other products),
or to NMDA, but not to ANP (Teunissen et al., 2000). Con-
versely, prolonged exposure to ANP elevated cGMP in an
oligodendrocyte-like cell line (Yoshioka et al., 2000) and mye-
lin purified from rat brainstem was reported to contain gua-
nylyl cyclase activity that was insensitive to sodium
nitroprusside, suggesting a natriuretic peptide receptor-
associated guanylyl cyclase (Chakraborty and Ledeen, 1993).
Together, these previous studies are consistent with oligoden-
drocytes having the capacity to generate cGMP on stimula-
tion by NO and/or ANP.
In the rat cerebellar slices, both NO and ANP raised
cGMP in oligodendrocytes from around postnatal day 8
through to adulthood, findings that differ from those
reported using the corpus callosum with respect to both age-
dependence and sensitivity to ANP (Tanaka et al., 1997),
pointing to a possible heterogeneity amongst oligodendrocytes
in different brain regions. Oligodendrocytes in 10-day-old rat
hippocampal slices failed to display cGMP immunostaining
after exposure to exogenous NO plus BAY 41-2272 (Bartus
et al., 2013) but these experiments were conducted in the
presence of a selective inhibitor of phosphodiesterase-2, an
enzyme that may not feature prominently in oligodendrocyte
cGMP breakdown, so that cGMP (if generated) may have
remained below detection. In the present experiments, oligo-
dendrocyte cGMP immunostaining in response to NO was
found not only in slices of cerebellum but also in slices of
brainstem and in cultures derived from the cerebral cortex,
indicating that it is likely to be a common property of this
cell type. An exception was in the rodent optic nerve where
axons, but not astrocytes or oligodendrocytes, exhibited NO-
sensitivity, a result that agrees with previous findings
(Garthwaite et al., 1999, 2006). Instead, beyond 7 days of
age, rat optic nerve oligodendrocytes responded to ANP or
CNP, indicating that these particular oligodendrocytes prefer-
entially express transmembrane guanylyl cyclase-coupled
receptors. Given the similar potencies of ANP and CNP, the
optic nerve oligodendrocytes presumably contain both sub-
types of receptors (NPR-A and -B) whereas cerebellar cGMP
in the guinea-pig is much more sensitive to ANP than to
CNP (Hernandez et al., 1994), suggesting that NPR-A recep-
tors dominate.
While being a valuable technique, cGMP immunohisto-
chemistry suffers the limitation of not being sensitive to the
submicromolar cGMP concentrations that are likely to be
important physiologically (Bartus et al., 2013). The use of
allosteric enhancers of NO-activated guanylyl cyclase such as
BAY 41-2272 help address this deficiency by boosting the
guanylyl cyclase activity sustained by low NO concentrations
sufficiently to elevate cGMP into the detectable range. In this
respect, physiological NO signals in the brain are likely to be
in the picomolar-nanomolar range, which is at the base of the
NO concentration-response curve for its receptors in cells
(Hall and Garthwaite, 2009). By exploiting allosteric
enhancers of this activity, our experiments showed that endo-
genously produced NO was able to access oligodendrocytes in
cerebellar slices. Unlike in optic nerve (Garthwaite et al.,
2006) the experiments all pointed to nNOS (rather than
eNOS) being the prominent isoform governing the basal NO
tone in the cerebellum. Here, granule cells are the nNOS-
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expressing neurones physically closest to oligodendrocytes and
so they represent the most likely cellular origins of the NO
signals (oligodendrocytes themselves apparently do not con-
tain NO synthase; Keilhoff et al., 1998). Although NMDA
receptor stimulation is an effective stimulus for NO genera-
tion by granule cells (Wood et al., 2011), the nNOS activity
that is transduced into oligodendrocyte cGMP accumulation
was independent of ongoing glutamate receptor stimulation,
suggesting that it is maintained by an atypical mechanism.
Possibilities include stimulation by Ca21 entering through
voltage-dependent Ca21-channels or, by analogy with eNOS
(Fulton et al., 2001), nNOS becoming active at resting Ca21
concentrations after being phosphorylated.
Concerning endogenous sources of ANP, a previous
study failed to detect the peptide in the cerebellum by radio-
immunoassay or immunohistochemistry (Kawata et al., 1985)
whereas, elsewhere in the brain, ANP has been found mainly
in neurones or astrocytes (Cao and Yang, 2008). Our finding
that ANP is associated with blood vessels in the developing
cerebellum, as are both ANP and CNP in the developing
optic nerve, signifies that there might be a local peptidergic
signaling pathway able to raise cGMP in oligodendrocytes.
Myelination in the rat cerebellum begins in the central
white matter at around postnatal day 6 and proceeds along
the axial core of the lobules to appear in the internal granule
cell layer 4–6 days later (Gianola et al., 2003; Reynolds and
Wilkin, 1988). The development of oligodendrocyte NO-
sensitivity, being undetectable at postnatal day 3 and promi-
nent at day 8, would be consistent with a role in this process.
Tests of this possibility using cortical cultures showed a strik-
ing effect of NO or cGMP on oligodendrocyte morphology,
exhibited as a shift to a greatly enhanced arborization. Based
on a previous classification, the cells shifted from a predomi-
nantly type I/II to a type III/IV morphology and, in this
respect, closely resembled the changes of cultured cortical oli-
godendrocytes recorded on exposure to adenosine (Stevens
et al., 2002). From calculations (see Materials and Methods),
the NO concentration produced by the maximally-effective
donor concentration in these experiments (10 nM DETA/
NO) peaks at 88 pM after 50 min and then declines to 40
pM after 24 h. These NO concentrations are similar to the
ones recorded from the internal granule cell layer in 10-day-
old rat cerebellar slices following brief (45 s) stimulation with
a half-maximally-effective concentration of NMDA (Wood
et al., 2011). The donor concentration that was inactive on
its own (3 nM) is predicted to yield NO concentrations of
12–27 pM over 24 h, concentrations that may be below
detection (in the absence of BAY 41-2272), particularly in
cells with high cGMP phosphodiesterase activity (Batchelor
et al., 2010). That the effect of NO was enhanced by BAY
41-2272 and was mimicked by 8-bromo-cGMP at the submi-
cromolar concentrations relevant to activation of cGMP-
dependent protein kinases (Pohler et al., 1995) supports gua-
nylyl cyclase activation being the key pathway engaged by
NO to promote oligodendrocyte maturation.
Transduction of cGMP signals commonly occurs through
cGMP-dependent protein kinases (PKG), of which there are
two main types, PKGI and PKGII. PKGI has a restricted distri-
bution in the central nervous system whereas PKGII is wide-
spread and is present in putative oligodendrocytes (de Vente
et al., 2001) and an oligodendrocyte-like cell line (Yoshioka
et al., 2000), making this isoform the probable downstream tar-
get of NO or ANP. The subsequent steps leading to the mor-
phological development of oligodendrocytes remain unexplored,
but a number of possibilities exist. One substrate for PKGII is
glycogen synthase kinase-3b (GSK-3b), with the resulting phos-
phorylation leading to inhibition of enzyme activity and, in
chondrocytes, the hypertrophic differentiation needed for normal
development of the skeleton (Kawasaki et al., 2008). Likewise,
in oligodendrocytes, GSK-3b negatively influences differentia-
tion and myelination and its pharmacological inhibition has the
opposite effect and promotes remyelination in focal demyeli-
nated lesions in vivo (Azim and Butt, 2011). In the peripheral
nervous system, inhibition of GSK-3b similarly enhances
Schwann cell differentiation and axon myelination (Makoukji
et al., 2012; Ogata et al., 2004). Hence, inhibition of GSK-3b
by PGKII-mediated phosphorylation could plausibly account for
our observations. Alternatively, a putative PKG substrate in oli-
godendrocytes is the transcription factor Olig1 which, on phos-
phorylation, locates in the cytoplasm to evoke morphological
changes similar to those described here in response to NO or 8-
bromo-cGMP (Niu et al., 2012). Also PKGII is a potent regula-
tor of gene expression in glioma cells (Gudi et al., 1999), partic-
ularly under conditions of raised intracellular Ca21, although
such an action in oligodendrocytes has not been tested.
Examination of our conclusions in vivo will be an impor-
tant future step, but some pertinent evidence already exists. In
rodents, inhaling air supplemented with NO (5 or 20 ppm)
during the first postnatal week was found to enhance myelina-
tion in the corpus callosum in the 7- or 14-day-old animal,
whereas inhibition of NO synthase activity over the same period
significantly reduced myelin density, an effect that could be
abrogated by administering inhaled NO (Olivier et al., 2010).
Also, mice deficient in nNOS exhibited a delay in remyelination
following chemical demyelination (Linares et al., 2006). These
findings provide partial support for a role of the NO/cGMP
pathway in oligodendrocyte maturation in vivo.
The development of oligodendrocytes into myelinating
cells involves a complex interplay between intrinsic and
extrinsic factors. Amongst the latter, axon-derived ATP (giv-
ing rise to extracellular adenosine) and glutamate have been
implicated as local drivers of oligodendrocyte maturation and
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axon myelination (Emery, 2010; Zuchero and Barres, 2013).
Our results add NO to the list of putative neuronally-derived
factors but, in the cerebellum at least, the axons undergoing
myelination do not contain detectable NO synthase, making
a localized mechanism unlikely. Rather, NO produced in the
nearby granule cells may be acting more as a volume trans-
mitter to enable the myelination of afferent and efferent
axons to keep pace with the activity of the cerebellum as it
develops. In the corpus callosum, intrinsic nNOS neurones
(Barbaresi et al., 2014; Rockland and Nayyar, 2012) may per-
form this role. By analogy with other brain areas (Gibson
et al., 2014; Young et al., 2013), the persistence of this signal-
ing pathway into adulthood in the cerebellum could be sig-
nificant for the adaptive changes in myelination that may be
of importance for adult motor learning.
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